AbbVie Inc. is 113.2x more valuable than NewAmsterdam Pharma Company N.V. by market capitalization ($402.35 B vs $3.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NAMS | ABBV |
|---|---|---|
| Market cap | $3.55 B | $402.35 B |
| US-listed rank | #1689 | #31 |
| Revenue (latest FY) | $22.50M | $61.16B |
| Net income (latest FY) | -$203.00M | $4.23B |
| Net margin | -902.1% | 6.9% |
| P/E (trailing FY) | - | 95.2 |
| SEC filings | 386 | 1,008 |
AbbVie Inc. is 113.2x more valuable than NewAmsterdam Pharma Company N.V. by market capitalization ($402.35 B vs $3.55 B).
In their latest fiscal years, NewAmsterdam Pharma Company N.V. reported $22.50M in revenue while AbbVie Inc. reported $61.16B.
Full pages: NewAmsterdam Pharma Company N.V. and AbbVie Inc., or browse the full rankings.